Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people

  • Technology appraisal guidance
  • TA455
  • Published: 
Download guidance (PDF)

6 Recommendations for research

6.1

Trials that evaluate utility values (using generic preference-based measures) in children and young people with severe psoriasis are needed to better inform future cost–utility analyses.